ad

Is Jupiter Life Line Hospitals the Best Stock in Its Sector? A Look at the Numbers

Jupiter Life Line Hospitals CMP Rs 242 (15 Oct 2026). Market cap Rs 8,020 Cr. ROE 12.56%. P/E 42.70x versus Industry P/E 61.23x.


15 Oct 2026 • 10:00 am

Is Jupiter Life Line Hospitals the Best Stock in Its Sector? A Look at the Numbers

Quick Answer

Jupiter Life Line Hospitals is one of the names investors compare when screening the Healthcare sector. Whether it is the best stock in its sector depends on whether an investor prioritises return ratios, valuation or balance sheet strength. This article sets it against two named peers and the sector benchmark so you can judge for yourself.

Is Jupiter Life Line Hospitals the best stock in its sector? The stock trades on the NSE at Rs 242 as of 15 October 2026, within its 52-week range of Rs 235.60 to Rs 340.00. The sections below cover the business, the key ratios, a peer comparison and a closer look at valuation.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About Jupiter Life Line Hospitals

Jupiter Life Line Hospitals Ltd, headquartered in Thane, operates multi specialty hospitals in western and central India, including Thane, Pune and Indore. Its hospitals offer services across cardiology, orthopaedics, neurology, maternity and critical care. At a market capitalisation of Rs 8,020 Cr, it is tracked as part of the Healthcare sector on Univest.

Is Jupiter Life Line Hospitals the Best Stock in Its Sector?

Jupiter Life Line Hospitals makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, backed by its return on equity. Jupiter Life Line Hospitals' 42.70x P/E is below the 61.23x Industry P/E and Rainbow Children's Medicare at 43.38x, though above Narayana Hrudayalaya at 42.28x, while its 12.56% ROE is lower than Narayana Hrudayalaya at 17.76% and Rainbow Children's Medicare at 16.89%, and its debt to equity ratio of 0.38 is below Narayana Hrudayalaya at 1.29 and Rainbow Children's Medicare at 0.54.

Metric Jupiter Life Line Hospitals
CMP (NSE) Rs 242.00
52-Week High / Low Rs 340.00 / Rs 235.60
Market Cap Rs 8,020 Cr
P/E (TTM) vs Industry P/E 42.70x vs 61.23x
P/B 5.19
ROE 12.56%
EPS (TTM) Rs 5.73
Dividend Yield 0.08%
Debt to Equity 0.38

Compare Jupiter Life Line Hospitals Against Other Healthcare Sector Stocks

How Jupiter Life Line Hospitals Compares Against Its Healthcare Sector Peers

The table below sets Jupiter Life Line Hospitals against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company Market Cap (Rs Cr) P/E ROE Debt to Equity
Jupiter Life Line Hospitals 8,020 42.70 12.56% 0.38
Narayana Hrudayalaya 34,527 42.28 17.76% 1.29
Rainbow Children's Medicare 12,593 43.38 16.89% 0.54
Peer average (2 companies) - 42.83 17.33% 0.92

Measured against the peer averages, Jupiter Life Line Hospitals' P/E is almost level with the 42.83x average, and its ROE is 4.77 percentage points below the 17.33% average. An average of just two companies is a rough guide, so treat the gap as a pointer for further research and not as a verdict.

What Makes Jupiter Life Line Hospitals Worth Watching in Healthcare

  • Scale: At Rs 8,020 Cr, its market capitalisation is smaller than Narayana Hrudayalaya (Rs 34,527 Cr) and Rainbow Children's Medicare (Rs 12,593 Cr), which is a useful reminder that the peers differ in size as well as in valuation.
  • Sector drivers: Bed additions, occupancy and a richer mix of complex procedures lift revenue per bed for hospital operators.
  • Key risk: Hospital expansion needs heavy capital and takes time to ramp up, so near term returns can lag the spending.

Jupiter Life Line Hospitals Valuation: Is It Justified?

At a P/B ratio of 5.19, the market pays about Rs 5.19 for every rupee of book value, and the EPS (TTM) of Rs 5.73 is the earnings base behind the P/E. The stock trades about 29 percent below its 52-week high and about 3 percent above its 52-week low. The dividend yield of 0.08% is a modest income component, so returns depend mainly on the share price. As with any single stock, investors should weigh these figures against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Oracle Financial Services Software the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Jupiter Life Line Hospitals and other Healthcare sector stocks.

How to Track Jupiter Life Line Hospitals Before You Invest

Before deciding whether Jupiter Life Line Hospitals deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

  1. Open the Univest Screener and search for Jupiter Life Line Hospitals to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
  2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
  3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
  4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Jupiter Life Line Hospitals gives investors a clear set of numbers to work with, from returns and valuation to leverage and peer standing. Whether it earns the label of best stock in Healthcare depends on how much weight you give each of them and on how the business executes from here. Because the stock trades below its sector benchmark, the open question is whether earnings growth will close that gap or whether the discount is deserved. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Is Jupiter Life Line Hospitals the best stock in its sector?

Ans. There is no single definitive answer, because the best stock in a sector depends on whether an investor is prioritising returns, valuation or balance sheet strength. Jupiter Life Line Hospitals has a 12.56% ROE and trades at 42.70x P/E against a 61.23x Industry P/E. Against the 2 peers compared in this article, its ROE is below the 17.33% peer average and its P/E is below the 42.83x peer average. Its debt to equity ratio of 0.38 is below the 0.92 peer average, which matters because borrowing can inflate returns and add risk when business conditions weaken. These figures are best read together rather than in isolation, and they work as a starting point for your own research and not as a verdict.

What is the current share price of Jupiter Life Line Hospitals?

Ans. Jupiter Life Line Hospitals was trading at Rs 242.00 on the NSE as of 15 October 2026, and its 52-week range runs from Rs 235.60 to Rs 340.00. That leaves the share price 29 percent short of the 52-week high and 3 percent clear of the 52-week low. Its market capitalisation is Rs 8,020 Cr and its EPS (TTM) is Rs 5.73, which is the earnings figure behind the 42.70x P/E. Share prices change through the trading day, so check the live quote on Univest before acting on any number here.

What sector does Jupiter Life Line Hospitals belong to?

Ans. Jupiter Life Line Hospitals is classified under the Healthcare sector on Univest, and that group of listed companies is the reference point for the 61.23x Industry P/E used in this article. The 2 named peers compared here are Narayana Hrudayalaya and Rainbow Children's Medicare, chosen as comparable listed names so that the P/E, ROE and debt figures come from the same live data source. Investors who want a wider view can compare more Healthcare sector stocks on the Univest Screener, since no two companies in a sector have exactly the same business mix.

How does Jupiter Life Line Hospitals compare to its sector peers on P/E?

Ans. Jupiter Life Line Hospitals' P/E of 42.70x is below the 42.83x average of the 2 named peers, with Narayana Hrudayalaya at 42.28x and Rainbow Children's Medicare at 43.38x. It also sits below the 61.23x Industry P/E, which is the benchmark for the wider Healthcare sector. A P/E that is below a peer average can reflect a valuation discount or premium, but it can also reflect different growth or return expectations, so it should be read alongside ROE and debt. Its P/B ratio of 5.19 gives one more view of how the market values its book value.

What is Jupiter Life Line Hospitals' return on equity?

Ans. Jupiter Life Line Hospitals reported a return on equity of 12.56%, which is below the 17.33% average of its named peers, with Narayana Hrudayalaya at 17.76% and Rainbow Children's Medicare at 16.89%. ROE shows how much profit a company generates on every rupee of shareholders' equity, so a higher figure generally points to more efficient use of capital. ROE is easier to trust when leverage is modest, and here the debt to equity ratio is 0.38 against a peer average of 0.92. It is worth checking whether the ROE has been stable over several years rather than relying on a single reading.

Should I invest in Jupiter Life Line Hospitals based on its sector position?

Ans. Sector position is only one input into an investment decision. Jupiter Life Line Hospitals has a 12.56% ROE and a 42.70x P/E, which make it worth researching further, and its dividend yield is 0.08%. You should also weigh its business outlook, earnings consistency, debt levels, your investment horizon and your own risk appetite before buying. Spreading money across several stocks and sectors reduces concentration risk, and this article is educational content, not investment advice. For personalised guidance, consult a SEBI-registered advisor.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down